<DOC>
	<DOC>NCT00543361</DOC>
	<brief_summary>The purpose of the study is to assess how MK0767, compared to Metformin, performs in lowering blood glucose levels in patients whose Type II diabetes is not controlled by diet and exercise.</brief_summary>
	<brief_title>Study MK0767 and Metformin in Type 2 Diabetic Patients (0767-020)</brief_title>
	<detailed_description />
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Diabetes Mellitus, Type 2</mesh_term>
	<mesh_term>Metformin</mesh_term>
	<criteria>Patients are men and nonpregnant women ages 21 to 78 years Patients either not on antihyperglycemic medications (&gt;8 weeks), or being treated with a single oral antihyperglycemic agent &amp; willing to discontinue therapy for the duration of the study Patient has history of type 1 diabetes mellitus and or history of ketoacidosis Patients undergoing surgery within 30 days of Visit 1 Patients taking Warfin or Warfinlike anticoagulants Patients on a weight loss program with ongoing weight loss or starting an intensive exercise program within 4 weeks of Visit 1/Week 9</criteria>
	<gender>All</gender>
	<minimum_age>21 Years</minimum_age>
	<maximum_age>78 Years</maximum_age>
	<verification_date>June 2015</verification_date>
</DOC>